Jennifer Husson is an Infectious Disease physician affiliated with Moderna Therapeutics. OpenAlex indexes 39 publications with 734 citations (h-index 12); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
22 S Greene St
Baltimore, MD 212011544
Telephone
410-328-6110Registry record last updated 21 Apr 2015.
Clinical trials
- Impact of Sirolimus and Maraviroc on CCR5 Expression and the HIV-1 Reservoir in HIV-infected Kidney Transplant Recipients
Sponsor: University of Maryland, Baltimore
- HCV Treatment Immune Response With Grazoprevir/Elbasvir Before or After Renal Transplant
Sponsor: University of Maryland, Baltimore
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medline Industries LPProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor58.1%Epclusa100%Part D<11 patientsPenem Antibacterial41.9%Ertapenem100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boost
Science Translational Medicine
2026 - Impact of Maraviroc on Circulating and Tissue Markers of Kidney Transplant Recipients with HIV
American Journal of Transplantation
2025 - A Phase 2 Extension Trial of the Safety and Immunogenicity of Cytomegalovirus mRNA-1647 Vaccine Through 36 Months in Healthy Adults
American Journal of Obstetrics and Gynecology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Brendan Weiss, MD
Moderna Therapeutics
Rituparna Das
Moderna Therapeutics
Walter Straus, MD
Moderna Therapeutics
Lori Panther, MD, MPH
Moderna Therapeutics
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
Derrick W. Crook
John Radcliffe Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”